[ad_1]
Sinopharm, a Chinese company working on two vaccines against COVID-19, mass production begins. President Liu Jingzhen, according to the English-language state television CGTN, said at the press conference on research and development so far, that Sinopharm “is ready to begin large-scale production of vaccines to ensure sufficient and safe supplies.” There China plans to produce 610 million doses of vaccines by the end of the year, confirmed Zheng Zhongwei, head of the Covid-19 vaccine development working group, adding that production will increase in 2021 to meet national and global demand. .
Covid, Director of Oxford Vaccine: “We will not be back to normal before summer 2021”
Vaccino, Conte: “First doses in December, but spring is expected to contain the pandemic”
Sixty thousand doses administered in China
China has 13 vaccines against Covid-19 in clinical phase, of which 4 arrived in phase 3, the last one: the doses administered so far have affected 60,000 people who have not reported serious side effects. According to Tian Baoguo, deputy director of the Ministry of Science and Technology, during a press conference in Beijing. Tian added, according to local media, that all vaccine candidates are currently proven to be safe.
Last updated: 16:05
© REPRODUCTION RESERVED
[ad_2]